Yahoo Web Search

Search results

    • UK NICE backs Exact’s Oncotype cancer genomic test

      UK NICE backs Exact’s Oncotype cancer genomic test

      Medical Device Network via Yahoo Finance· 5 days ago

      The Oncotype DX has 85% sensitivity in identifying postmenopausal patients whose cancer outcomes are not likely improved by chemotherapy. The Oncotype DX...